The role of cyclic AMP and its protein kinase in mediating acetylcholine release and the action of adenosine at frog motor nerve endings
Open Access
- 1 October 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 101 (2) , 311-318
- https://doi.org/10.1111/j.1476-5381.1990.tb12707.x
Abstract
1 The importance of adenosine 3′:5′-cyclic monophosphate (cyclic AMP) and its protein kinase (protein kinase A, PKA) in promoting acetylcholine (ACh) release was studied at frog motor nerve endings. The effects of cyclic AMP-dependent protein phosphorylation on the action of adenosine receptor agonists were also investigated. 2 Cyclic AMP was delivered to a local region of the cytoplasm just beneath the plasma membrane of motor nerve endings using phospholipid vesicles (liposomes) as a vehicle. Cyclic AMP in liposomes produced a parallel reduction in the mean level of evoked ACh release (m) and spontaneous ACh release (miniature endplate potential frequency; m.e.p.p.f) in most experiments. These inhibitory effects of cyclic AMP on quantal ACh release resemble the action of adenosine. 3 The effects of global increases in cytoplasmic cyclic AMP concentrations using lipophilic cyclic AMP analogues were generally different from those observed with cyclic AMP. 8-(4-Chlorophenylthio) cyclic AMP (CPT cyclic AMP) produced approximately two fold increases in m and m.e.p.p.f. Dibutyryl cyclic AMP (db cyclic AMP) also increased m and m.e.p.p.f, with the effect on m being smaller and more variable. 4 All three cyclic AMP analogues reduced the effects of adenosine receptor agonists on spontaneous and evoked ACh release. 5 The roles of protein phosphorylation in mediating ACh release and the inhibitory effects of adenosine were studied with the protein kinase inhibitor H7. H7 (30–100 μm) produced no consistent effect on evoked or spontaneous ACh release. At these concentrations, however, H7 exerted an unfortunate inhibitory action on the nicotinic ACh receptor/ion channel. 6 H7 prevented the increases in spontaneous ACh release produced by CPT cyclic AMP (250 μm). Thus H7 is likely to inhibit PK A in frog motor nerve endings. 7 H7 did not alter the inhibitory effect of adenosine on evoked and spontaneous ACh release. 8 The results suggest: (i) that the adenylyl cyclase-cyclic AMP-PK A system is compartmentalized within the motor nerve terminal, (ii) that phosphorylation does not play a major role in ACh release and (iii) the cyclic AMP-PK A system modulates rather than mediates the inhibitory effects of adenosine.This publication has 41 references indexed in Scilit:
- Transduction mechanism involving the presynaptic adenosine receptor at mouse motor nerve terminalsNeuroscience Letters, 1989
- Pharmacological elevation of cyclic AMP and transmitter release at the mouse neuromuscular junctionCanadian Journal of Physiology and Pharmacology, 1988
- Inhibition of transmitter release by adenosine: are Ca2+ currents depressed or are the intracellular effects of Ca2+ impaired?Trends in Pharmacological Sciences, 1986
- CALCIUM, CYCLIC AMP AND HORMONE ACTIONClinical Endocrinology, 1985
- A unified theory of presynaptic chemical neurotransmissionJournal of Theoretical Biology, 1985
- Second messengers, phosphorylation and neurotransmitter releaseTrends in Neurosciences, 1985
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Sustained potentiation of transmitter release by adrenaline and dibutyryl cyclic AMP in sympathetic gangliaNature, 1981
- Cellular uptake of cyclic AMP captured within phospholipid vehicles and effect on cell-growth behaviourBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- A Cyclic Adenosine Monophosphate Link in the Catecholamine Enhancement of Transmitter Release at the Neuromuscular JunctionThe Journal of general physiology, 1974